Literature DB >> 15612998

The killing effect of cryptolepine on Staphylococcus aureus.

I K Sawer1, M I Berry, J L Ford.   

Abstract

AIM: This study was undertaken to further examine the antimicrobial actions of the alkaloid cryptolepine. METHODS AND
RESULTS: The minimum inhibitory concentration (MIC) of cryptolepine against Staphylococcus aureus was determined using the broth dilution method. Time-kill kinetics and scanning electron microscopy (SEM) techniques were employed to monitor the survival characteristics and the changes in morphologies respectively of staphylococci in the presence of cryptolepine. A notable antistaphylococcal activity was recorded for cryptolepine (MIC against S. aureus NCTC 10788=5 microg ml(-1)). Cryptolepine appears to have a lytic effect on S. aureus as seen in SEM photomicrographs following 3, 6 or 24 h treatment with 4X MIC, i.e. 20 microg ml(-1) of cryptolepine. The surface morphological appearance of the staphylococcal cells was also altered. The lytic effect appeared to coincide with low viable counts recorded in survival curves following treatment with cryptolepine. SIGNIFICANCE AND IMPACT OF THE STUDY: These findings demonstrate that lysis occurs when susceptible organisms are exposed to cryptolepine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15612998     DOI: 10.1111/j.1472-765X.2004.01625.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  6 in total

1.  Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor.

Authors:  Subray S Hegde; Matthew W Vetting; Lesley A Mitchenall; Anthony Maxwell; John S Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  Synergistic anti-malarial action of cryptolepine and artemisinins.

Authors:  Arnold D Forkuo; Charles Ansah; Kwesi M Boadu; Johnson N Boampong; Elvis O Ameyaw; Ben A Gyan; Andrea T Arku; Michael F Ofori
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

Review 3.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

4.  Genomewide expression profiling of cryptolepine-induced toxicity in Saccharomyces cerevisiae.

Authors:  Marta Rojas; Colin W Wright; Benjamin Piña; José Portugal
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

5.  In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta.

Authors:  Felix C Mills-Robertson; Samuel C K Tay; Goerge Duker-Eshun; Williams Walana; Kingsley Badu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-06-18       Impact factor: 3.944

Review 6.  Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight.

Authors:  Champa Keeya Tudu; Anustup Bandyopadhyay; Manoj Kumar; Tuyelee Das; Samapika Nandy; Mimosa Ghorai; Abilash Valsala Gopalakrishnan; Jarosław Proćków; Abhijit Dey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-17       Impact factor: 3.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.